
Garen Gotfredson
Examiner (ID: 4066, Phone: (571)270-3468 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 650 |
| Issued Applications | 234 |
| Pending Applications | 86 |
| Abandoned Applications | 346 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17434768
[patent_doc_number] => 11260074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Compositions and related methods for reconstituting the immune system of a subject
[patent_app_type] => utility
[patent_app_number] => 16/818876
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10021
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818876 | Compositions and related methods for reconstituting the immune system of a subject | Mar 12, 2020 | Issued |
Array
(
[id] => 16108419
[patent_doc_number] => 20200206232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 16/817689
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16817689
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/817689 | Tofacitinib oral sustained release dosage forms | Mar 12, 2020 | Issued |
Array
(
[id] => 17944240
[patent_doc_number] => 20220331257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => LIQUID PHARMACEUTICAL COMPOSITIONS WITH STABLE DRUG RELEASE PROFILES
[patent_app_type] => utility
[patent_app_number] => 17/435000
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435000 | LIQUID PHARMACEUTICAL COMPOSITIONS WITH STABLE DRUG RELEASE PROFILES | Feb 27, 2020 | Pending |
Array
(
[id] => 16052915
[patent_doc_number] => 20200188312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => COMPOSITION COMPRISING AN ORGANIC LIQUID DILUENT AND A SPECIFIC HYDROXYALKYL METHYLCELLULOSE
[patent_app_type] => utility
[patent_app_number] => 16/799020
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799020 | COMPOSITION COMPRISING AN ORGANIC LIQUID DILUENT AND A SPECIFIC HYDROXYALKYL METHYLCELLULOSE | Feb 23, 2020 | Abandoned |
Array
(
[id] => 16052897
[patent_doc_number] => 20200188303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => ACTIVE INGREDIENT CONTAINING STABILISED SOLID MEDICINAL FORMS AND METHODS FOR THE PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/795900
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795900
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795900 | ACTIVE INGREDIENT CONTAINING STABILISED SOLID MEDICINAL FORMS AND METHODS FOR THE PRODUCTION THEREOF | Feb 19, 2020 | Abandoned |
Array
(
[id] => 16998283
[patent_doc_number] => 11077065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Process for preparing an acid resistant cellulose capsule
[patent_app_type] => utility
[patent_app_number] => 16/793179
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4566
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16793179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/793179 | Process for preparing an acid resistant cellulose capsule | Feb 17, 2020 | Issued |
Array
(
[id] => 17561566
[patent_doc_number] => 20220125715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => COMPARTMENTALIZED DRUG DELIVERY DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/430521
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430521 | COMPARTMENTALIZED DRUG DELIVERY DEVICES | Feb 13, 2020 | Abandoned |
Array
(
[id] => 17799027
[patent_doc_number] => 11413294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/778526
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13366
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/778526 | Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof | Jan 30, 2020 | Issued |
Array
(
[id] => 16612016
[patent_doc_number] => 20210030669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => GASTROINTESTINAL SITE-SPECIFIC ORAL VACCINATION FORMULATIONS ACTIVE ON THE ILEUM AND APPENDIX
[patent_app_type] => utility
[patent_app_number] => 16/778120
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/778120 | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix | Jan 30, 2020 | Issued |
Array
(
[id] => 18184467
[patent_doc_number] => 20230045197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => PET FOOD
[patent_app_type] => utility
[patent_app_number] => 17/786444
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786444 | PET FOOD | Jan 26, 2020 | Pending |
Array
(
[id] => 19111066
[patent_doc_number] => 20240122816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN
[patent_app_type] => utility
[patent_app_number] => 17/768677
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768677
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768677 | ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN | Jan 16, 2020 | Pending |
Array
(
[id] => 16108477
[patent_doc_number] => 20200206261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => COMPOSITION AND METHODS FOR GENERATING AND SUSTAINING MOLECULAR HYDROGEN (H2) IN AQUEOUS SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/736749
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736749 | Composition and methods for generating and sustaining molecular hydrogen (H2) in aqueous systems | Jan 6, 2020 | Issued |
Array
(
[id] => 20270684
[patent_doc_number] => 12440448
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Powder, wound-covering material, adhesion prevention material, hemostatic material, and production method for powder
[patent_app_type] => utility
[patent_app_number] => 17/414510
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 8732
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414510 | Powder, wound-covering material, adhesion prevention material, hemostatic material, and production method for powder | Dec 19, 2019 | Issued |
Array
(
[id] => 17532244
[patent_doc_number] => 20220110853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/422346
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422346
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422346 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | Dec 17, 2019 | Pending |
Array
(
[id] => 17368438
[patent_doc_number] => 20220023490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => WOUND DRESSINGS INCLUDING PVP-CITRIC ACID COPOLYMER
[patent_app_type] => utility
[patent_app_number] => 17/413715
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413715 | WOUND DRESSINGS INCLUDING PVP-CITRIC ACID COPOLYMER | Dec 16, 2019 | Abandoned |
Array
(
[id] => 16784911
[patent_doc_number] => 10987310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
[patent_app_type] => utility
[patent_app_number] => 16/712260
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 13975
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712260 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Dec 11, 2019 | Issued |
Array
(
[id] => 15764593
[patent_doc_number] => 20200113314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => SHEET, IMAGE PROCESSING APPARATUS, AND METHOD FOR PROCESSING IMAGE
[patent_app_type] => utility
[patent_app_number] => 16/712857
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712857
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712857 | SHEET, IMAGE PROCESSING APPARATUS, AND METHOD FOR PROCESSING IMAGE | Dec 11, 2019 | Abandoned |
Array
(
[id] => 16204821
[patent_doc_number] => 20200237811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => HYDROGEN SULFIDE SUSTAINED RELEASING DRESSING AND MANUFACTURING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/705199
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16705199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/705199 | Hydrogen sulfide sustained releasing dressing and manufacturing method thereof | Dec 4, 2019 | Issued |
Array
(
[id] => 18064353
[patent_doc_number] => 20220395440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA NANOSPHERES
[patent_app_type] => utility
[patent_app_number] => 17/772897
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772897 | SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA NANOSPHERES | Oct 29, 2019 | Pending |
Array
(
[id] => 17212967
[patent_doc_number] => 20210346303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COATING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/286226
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286226
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286226 | COATING METHOD | Oct 16, 2019 | Abandoned |